Cargando…
Bevacizumab‐enhanced antitumor effect of 5‐fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2‐specificity protein 1 pathway
Bevacizumab (Bv) can be used synergistically with fluoropyrimidine‐based chemotherapy to treat colorectal cancer. Whether and how it affects the delivery of fluoropyrimidine drugs is unknown. The present study aimed to explore the effect of Bv on the delivery of 5‐fluorouracil (5‐FU) to tumors and t...
Autores principales: | Liu, Wenyue, Zhang, Jingwei, Yao, Xuequan, Jiang, Chao, Ni, Ping, Cheng, Lingge, Liu, Jiali, Ni, Suiying, Chen, Qianying, Li, Qingran, Zhou, Kai, Wang, Guangji, Zhou, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172063/ https://www.ncbi.nlm.nih.gov/pubmed/30151975 http://dx.doi.org/10.1111/cas.13779 |
Ejemplares similares
-
Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer
por: KIMURA, YUTAKA, et al.
Publicado: (2016) -
Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.
por: Griffiths, L., et al.
Publicado: (1997) -
Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity
por: de Bruin, M, et al.
Publicado: (2003) -
Identification of bioactive anti-angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics
por: Zhong, Chongjin, et al.
Publicado: (2020) -
Significance of Thymidine Phosphorylase/Platelet‐derived Endothelial Cell Growth Factor in Carcinoma of the Papilla of Vater
por: Zhao, Bin, et al.
Publicado: (2000)